Dr. Daniel Morganstern is a hematologist/oncologist on the Hartford Hospital medical staff. He earned his medical degree from the State University of New York in Brooklyn, and completed a residency in internal medicine at New England Deaconess Hospital in Boston and a fellowship in hematology/oncology at Beth Israel Deaconess Medical Center in Boston. He also completed a clinical fellowship and research fellowship, both in medicine, at Harvard Medical School.
He has worked for years at Dana-Farber/Brigham and Women’s Cancer Center specializing in breast oncology where he was also co-director of medical oncology for the Breast Cancer Personalized Risk Assessment, Education and Prevention Clinic, which he co-founded. He was previously affiliated with Lahey Clinic in Boston as a researcher focused on prostate cancer, another hormonally driven disease.
Currently, he is a member of the Alliance Cancer Prevention Committee, Alliance for Clinical Trials in Oncology and an ad hoc reviewer for the publication Cancer Medicine. His research interests include breast cancer genetics and prevention strategies, metastatic breast cancer, the use of preoperative endocrine therapy in breast cancer patients and male breast cancer.